ImmuGenyx Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

ImmuGenyx General Information

Description

Developer of a disease modeling platform designed to create realistic human-like models of blood cancers. The company's platform leverages the unique properties of advanced hematopoietic chimeras (AHC) for immuno and cell therapy treatment for diseases like leukemia and lymphoma, enabling medical researchers to develop and test new cell therapies involving immune cell reprogramming

Contact Information

Website
www.immugenyx.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 760 Parkside Avenue
  • Brooklyn
  • New York, NY 11226
  • United States
+1 (212)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 760 Parkside Avenue
  • Brooklyn
  • New York, NY 11226
  • United States
+1 (212)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ImmuGenyx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator Completed Startup
1. Corporate 16-Oct-2018 Completed Startup
To view ImmuGenyx’s complete valuation and funding history, request access »

ImmuGenyx Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Orgenesis Corporation
To view ImmuGenyx’s complete investors history, request access »

Ready to get started?

Request a free trial

ImmuGenyx FAQs

  • When was ImmuGenyx founded?

    ImmuGenyx was founded in 2018.

  • Where is ImmuGenyx headquartered?

    ImmuGenyx is headquartered in New York, NY.

  • What industry is ImmuGenyx in?

    ImmuGenyx’s primary industry is Drug Discovery.

  • Is ImmuGenyx a private or public company?

    ImmuGenyx is a Private company.

  • What is ImmuGenyx’s current revenue?

    The current revenue for ImmuGenyx is .

  • How much funding has ImmuGenyx raised over time?

    ImmuGenyx has raised $1M.

  • Who are ImmuGenyx’s investors?

    Orgenesis has invested in ImmuGenyx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process